Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
William Ransom & Son is a historic British pharmaceutical company founded in 1846, specializing in the development and manufacture of botanical extracts and natural products. As one of the UK's oldest pharmaceutical entities, it has long been a leader in phytopharmaceutical science, providing high-quality plant-based ingredients for the healthcare, food, and cosmetic industries. The company's expertise encompasses the entire supply chain, from sourcing raw botanical materials to advanced extraction and formulation processes. Following its acquisition by the Wasdell Group in 2011, the company has integrated its traditional botanical knowledge with modern manufacturing capabilities. Today, it operates as a specialist provider of natural medicines and galenicals, serving a global client base.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on William Ransom & Son.